1.8841 USD
+0.05 (+2.96%)
ChartMill assigns a Buy % Consensus number of 80% to VVOS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 5.1. This target is 170.69% above the current price.
- VVOS was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VVOS.
- In the previous month the buy percentage consensus was at a similar level.
- VVOS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-11-17 | HC Wainwright & Co. | Initiate | Buy |
| 2025-09-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-15 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-20 | Ascendiant Capital | Reiterate | Buy -> Buy |
| 2024-11-19 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-08-20 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-01-17 | Ascendiant Capital | Initiate | Buy |
| 2021-08-13 | Roth Capital | Maintains | Buy |
| 2021-05-18 | Roth Capital | Maintains | Buy |
VIVOS THERAPEUTICS INC / VVOS FAQ
What is the average price target for VIVOS THERAPEUTICS INC (VVOS) stock?
9 analysts have analysed VVOS and the average price target is 5.1 USD. This implies a price increase of 170.69% is expected in the next year compared to the current price of 1.8841.
How do analysts rate VIVOS THERAPEUTICS INC (VVOS)?
The consensus rating for VIVOS THERAPEUTICS INC (VVOS) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.